13,14-dihydro-15-keto-tetranor Prostaglandin E2
|
- $108 - $481
- Product name: 13,14-dihydro-15-keto-tetranor Prostaglandin E2
- CAS: 20675-85-8
- MF: C16H26O5
- MW: 298.37
- EINECS:
- MDL Number:MFCD18428006
- Synonyms:13,14-dihydro-15-keto-tetranor Prostaglandin E2;13,14-dihydro-15-keto-tetranor Prostaglandin E2 Exclusive;Cyclopentanepropanoic acid, 3-hydroxy-5-oxo-2-(3-oxooctyl)-, [1R-(1α,2β,3α)]- (9CI)
3 prices
Selected condition:
Brand
- Cayman Chemical
Package
- 10μg
- 25μg
- 50μg
- ManufacturerCayman Chemical
- Product number13101
- Product description13,14-dihydro-15-keto-tetranor Prostaglandin E2 ≥95%
- Packaging10μg
- Price$108
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number13101
- Product description13,14-dihydro-15-keto-tetranor Prostaglandin E2 ≥95%
- Packaging25μg
- Price$256
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number13101
- Product description13,14-dihydro-15-keto-tetranor Prostaglandin E2 ≥95%
- Packaging50μg
- Price$481
- Updated2026-04-30
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Cayman Chemical | 13101 | 13,14-dihydro-15-keto-tetranor Prostaglandin E2 ≥95% | 10μg | $108 | 2026-04-30 | Buy |
| Cayman Chemical | 13101 | 13,14-dihydro-15-keto-tetranor Prostaglandin E2 ≥95% | 25μg | $256 | 2026-04-30 | Buy |
| Cayman Chemical | 13101 | 13,14-dihydro-15-keto-tetranor Prostaglandin E2 ≥95% | 50μg | $481 | 2026-04-30 | Buy |
Properties
Boiling point :497.7±30.0 °C(Predicted)
Density :1.127±0.06 g/cm3(Predicted)
solubility :DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): 1 mg/ml
pka :4.61±0.10(Predicted)
Density :1.127±0.06 g/cm3(Predicted)
solubility :DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): 1 mg/ml
pka :4.61±0.10(Predicted)
Safety Information
| Symbol(GHS): |
![]()
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | ||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
A common metabolic pathway for several prostaglandins (PG), including PGE2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor PGEM. 13,14-dihydro-15-keto tetranor PGE2 is a potential metabolite of PGE2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGE2 , which is known to have a short plasma half-life.Related product price
-
13,14-dihydro-15-keto-tetranor Prostaglandin D2
$116-17289.4 -
13,14-dihydro-15-keto Prostaglandin E2-d4
$128-454 -
363-23-5
$76-646





